CONSTELLIUM SE's ticker is CSTM and the CUSIP is F21107101. A total of 140 filers reported holding CONSTELLIUM SE in Q4 2020. The put-call ratio across all filers is 0.12 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $13,419,315 | -12.6% | 711,900 | +2.5% | 0.01% | -13.3% |
Q1 2024 | $15,350,752 | +30.3% | 694,290 | +17.6% | 0.02% | +25.0% |
Q4 2023 | $11,780,592 | +13.8% | 590,210 | +3.8% | 0.01% | 0.0% |
Q3 2023 | $10,352,524 | -5.0% | 568,820 | -10.2% | 0.01% | 0.0% |
Q2 2023 | $10,896,028 | -10.6% | 633,490 | -20.6% | 0.01% | -14.3% |
Q1 2023 | $12,188,550 | +73.0% | 797,680 | +33.9% | 0.01% | +75.0% |
Q4 2022 | $7,046,894 | +15.5% | 595,680 | -1.0% | 0.01% | +14.3% |
Q3 2022 | $6,103,000 | +67.2% | 601,880 | +117.8% | 0.01% | +75.0% |
Q2 2022 | $3,650,000 | -51.7% | 276,330 | -34.1% | 0.00% | -50.0% |
Q1 2022 | $7,550,000 | +17.2% | 419,470 | +16.6% | 0.01% | +33.3% |
Q4 2021 | $6,442,000 | -1.7% | 359,700 | +3.1% | 0.01% | 0.0% |
Q3 2021 | $6,555,000 | -9.4% | 349,050 | -8.6% | 0.01% | -14.3% |
Q2 2021 | $7,239,000 | +2.4% | 381,980 | -20.5% | 0.01% | 0.0% |
Q1 2021 | $7,067,000 | +27.2% | 480,750 | +21.1% | 0.01% | +16.7% |
Q4 2020 | $5,555,000 | +148.3% | 397,090 | +137.9% | 0.01% | +100.0% |
Q4 2019 | $2,237,000 | – | 166,910 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lancaster Investment Management | 2,078,199 | $39,029,000 | 92.29% |
OBERWEIS ASSET MANAGEMENT INC/ | 6,497,497 | $122,023,000 | 25.27% |
Bronson Point Management LLC | 1,630,000 | $30,611,000 | 13.38% |
Nut Tree Capital Management, LP | 3,300,000 | $61,974,000 | 13.17% |
Mountaineer Partners Management, LLC | 606,693 | $11,394,000 | 7.44% |
Bpifrance SA | 16,393,903 | $307,877,000 | 7.06% |
BEACONLIGHT CAPITAL, LLC | 825,091 | $15,495,000 | 6.77% |
Trellus Management Company, LLC | 364,100 | $6,838,000 | 4.98% |
Soapstone Management L.P. | 603,282 | $11,330,000 | 4.76% |
Bornite Capital Management LP | 350,000 | $6,573,000 | 3.52% |